The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(3-(4-chloro-2-fluorobenzyloxy)benzoyl)-3-hydroxycyclohex-2-en-1-one ID: ALA4549115
PubChem CID: 155549408
Max Phase: Preclinical
Molecular Formula: C20H16ClFO4
Molecular Weight: 374.80
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C1CCCC(O)=C1C(=O)c1cccc(OCc2ccc(Cl)cc2F)c1
Standard InChI: InChI=1S/C20H16ClFO4/c21-14-8-7-13(16(22)10-14)11-26-15-4-1-3-12(9-15)20(25)19-17(23)5-2-6-18(19)24/h1,3-4,7-10,23H,2,5-6,11H2
Standard InChI Key: HJVKUZDPBRBQPX-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
4.0433 -14.7342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0421 -15.5537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7502 -15.9627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4598 -15.5532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4570 -14.7306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7484 -14.3253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3355 -14.3257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3353 -13.5086 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6278 -14.7345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9182 -14.3190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2127 -14.7243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2087 -15.5418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9163 -15.9524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6280 -15.5455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9215 -13.5018 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.3349 -15.9555 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.1632 -14.3193 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8724 -14.7252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5786 -14.3140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2862 -14.7233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9919 -14.3127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9893 -13.4947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2751 -13.0889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5723 -13.5018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2873 -15.5405 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
9.6949 -13.0825 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
7 8 2 0
7 9 1 0
9 10 2 0
9 14 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
10 15 1 0
14 16 2 0
5 17 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
20 25 1 0
22 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 374.80Molecular Weight (Monoisotopic): 374.0721AlogP: 4.81#Rotatable Bonds: 5Polar Surface Area: 63.60Molecular Species: ACIDHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.35CX Basic pKa: ┄CX LogP: 4.31CX LogD: 1.39Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.60Np Likeness Score: -0.76
References 1. Ndikuryayo F, Kang WM, Wu FX, Yang WC, Yang GF.. (2019) Hydrophobicity-oriented drug design (HODD) of new human 4-hydroxyphenylpyruvate dioxygenase inhibitors., 166 [PMID:30684868 ] [10.1016/j.ejmech.2019.01.032 ]